ThinkSabio

$ENLV

$1.75▲ -3.8% YTD

4 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History
News
ENLV ▼ -3.8% - Enlivex Ltd.
CP $1.75▲ -3.8%Nov 2, 2026 · ThinkSabio Blog

$ENLV - Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response…

News
ENLV ▲ +4.4% - Enlivex Ltd.
CP $2.82▲ +4.4%Oct 28, 2026 · ThinkSabio Blog

$ENLV - Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis…

News
ENLV ▲ +6.3% - Enlivex Ltd.
CP $0.17▲ +6.3%Oct 27, 2026 · ThinkSabio Blog

$ENLV - Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal…

News
ENLV ▼ -10.0% - Enlivex Ltd.
CP $0.18▲ -10.0%Oct 22, 2026 · ThinkSabio Blog

$ENLV - Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026…